Failure of insulin-like growth factor-I (IGF-I) infusion to promote growth in protein-restricted rats despite normalization of serum IGF-I concentrations - PubMed (original) (raw)
Failure of insulin-like growth factor-I (IGF-I) infusion to promote growth in protein-restricted rats despite normalization of serum IGF-I concentrations
J P Thissen et al. Endocrinology. 1991 Feb.
Abstract
Dietary protein restriction in young rats induces GH resistance characterized by growth arrest and low serum insulin-like growth factor-I (IGF-I) concentrations. To determine whether the low serum IGF-I concentrations are responsible for the stunted growth, we infused 4-week-old protein-restricted rats with recombinant human IGF-I (300 micrograms/day) or rat GH (200 micrograms/100 g body wt/day) by osmotic minipump for 1 week. Despite the normalization of serum IGF-I concentrations by IGF-I infusion, carcass growth was not stimulated. In contrast, growth of the spleen and kidney was enhanced (+45% and +28%, respectively). Serum IGF-binding protein 3 (IGFBP-3), the principal carrier of IGF-I in the serum at this age, is decreased by 34% in protein-restricted animals and restored to normal by IGF-I infusion. Contrary to the selective effects of IGF-I on growth of protein-restricted rats, well nourished hypophysectomized rats infused with 150 micrograms/day recombinant human IGF-I showed a significant growth response, including carcass and organ growth and normalization of IGFBP-3 values. These responses indicate that our IGF-I preparation and mode of delivery were effective. We conclude that: 1) dietary protein restriction causes organ-specific resistance to the growth-promoting properties of exogenous IGF-I; 2) IGF-I mediates the stimulatory effects of growth hormone on IGFBP-3 synthesis; and 3) the absence of carcass growth in the presence of normal serum IGF-I concentrations during infusion of IGF-I suggests that the growth arrest that accompanies protein restriction is mediated in part by resistance to IGF-I.
Similar articles
- Evidence that pretranslational and translational defects decrease serum insulin-like growth factor-I concentrations during dietary protein restriction.
Thissen JP, Triest S, Moats-Staats BM, Underwood LE, Mauerhoff T, Maiter D, Ketelslegers JM. Thissen JP, et al. Endocrinology. 1991 Jul;129(1):429-35. doi: 10.1210/endo-129-1-429. Endocrinology. 1991. PMID: 2055198 - Effects of continuous infusion of insulin-like growth factor I and II, alone and in combination with thyroxine or growth hormone, on the neonatal hypophysectomized rat.
Glasscock GF, Hein AN, Miller JA, Hintz RL, Rosenfeld RG. Glasscock GF, et al. Endocrinology. 1992 Jan;130(1):203-10. doi: 10.1210/endo.130.1.1370151. Endocrinology. 1992. PMID: 1370151 - Divergent responses of serum insulin-like growth factor-I and liver growth hormone (GH) receptors to exogenous GH in protein-restricted rats.
Thissen JP, Triest S, Underwood LE, Maes M, Ketelslegers JM. Thissen JP, et al. Endocrinology. 1990 Feb;126(2):908-13. doi: 10.1210/endo-126-2-908. Endocrinology. 1990. PMID: 2298175 - Growth promotion by insulin-like growth factor I in hypophysectomized and diabetic rats.
Zapf J. Zapf J. Mol Cell Endocrinol. 1998 May 25;140(1-2):143-9. doi: 10.1016/s0303-7207(98)00042-2. Mol Cell Endocrinol. 1998. PMID: 9722182 Review. - Protein intake, IGF-1 and osteoporosis.
Bonjour JP, Schürch MA, Chevalley T, Ammann P, Rizzoli R. Bonjour JP, et al. Osteoporos Int. 1997;7 Suppl 3:S36-42. doi: 10.1007/BF03194340. Osteoporos Int. 1997. PMID: 9536300 Review. No abstract available.
Cited by
- Impact of health and lifestyle food supplements on periodontal tissues and health.
Spahr A, Divnic-Resnik T. Spahr A, et al. Periodontol 2000. 2022 Oct;90(1):146-175. doi: 10.1111/prd.12455. Epub 2022 Aug 2. Periodontol 2000. 2022. PMID: 35916868 Free PMC article. Review. - Essential Amino Acid Intake Is Required for Sustaining Serum Insulin-like Growth Factor-I Levels but Is Not Necessarily Needed for Body Growth.
Nishi H, Uchida K, Saito M, Yamanaka D, Nagata H, Tomoshige H, Miyata I, Ito K, Toyoshima Y, Takahashi SI, Hakuno F, Takenaka A. Nishi H, et al. Cells. 2022 May 2;11(9):1523. doi: 10.3390/cells11091523. Cells. 2022. PMID: 35563827 Free PMC article. - Regulation of body growth.
Lui JC, Garrison P, Baron J. Lui JC, et al. Curr Opin Pediatr. 2015 Aug;27(4):502-10. doi: 10.1097/MOP.0000000000000235. Curr Opin Pediatr. 2015. PMID: 26087427 Free PMC article. Review. - Determinants of GH resistance in malnutrition.
Fazeli PK, Klibanski A. Fazeli PK, et al. J Endocrinol. 2014 Jan 27;220(3):R57-65. doi: 10.1530/JOE-13-0477. Print 2014 Mar. J Endocrinol. 2014. PMID: 24363451 Free PMC article. Review. - Exogenous recombinant human growth hormone effects during suboptimal energy and zinc intake.
Rising R, Scaglia JF, Cole C, Tverskaya R, Duro D, Lifshitz F. Rising R, et al. Nutr Metab (Lond). 2005 Apr 7;2(1):10. doi: 10.1186/1743-7075-2-10. Nutr Metab (Lond). 2005. PMID: 15817131 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous